Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer
Clinical trial NCT00323882 · COMPLETED
Trial details
- NCT number
- NCT00323882
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2009-09-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.